Vincerx Pharma, Inc. (VINC) DCF Valuation

Vincerx Pharma, Inc. (VINC) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

Vincerx Pharma, Inc. (VINC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Vincerx Pharma, Inc. (VINC) valuation with this customizable DCF Calculator! Featuring real Vincerx Pharma, Inc. (VINC) financials and adjustable forecast inputs, you can test scenarios and uncover Vincerx Pharma, Inc. (VINC) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 -10.7 -62.7 -68.7 -42.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 5.7 .3 .9 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT .0 -16.4 -63.0 -69.6 -42.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .7 61.8 111.5 52.5 12.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 1.4 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 -1.2 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .5 2.0 4.1 2.5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -5.3 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT .0 -16.4 -25.0 -60.9 -42.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .0 -10.3 -28.4 -58.0 -44.0 -2.5 .0 .0 .0 .0
WACC, % 8.17 8.17 7.16 7.96 8.17 7.93 7.93 7.93 7.93 7.93
PV UFCF
SUM PV UFCF -2.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -10
Equity Value 8
Diluted Shares Outstanding, MM 21
Equity Value Per Share 0.37

What You Will Receive

  • Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled real VINC financials.
  • Accurate Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
  • Flexible Forecasting: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect Vincerx Pharma’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Centric Layout: Organized for clarity and ease of use, complete with step-by-step guidance.

Key Features

  • 🔍 Real-Life VINC Financials: Pre-filled historical and projected data for Vincerx Pharma, Inc. (VINC).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Vincerx's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Vincerx's valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file for Vincerx Pharma, Inc. (VINC).
  2. Step 2: Review Vincerx Pharma’s pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the outputs and leverage the results for your investment decisions.

Why Choose This Calculator for Vincerx Pharma, Inc. (VINC)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters to suit your specific analysis needs.
  • Real-Time Feedback: Instantly observe changes in Vincerx Pharma’s valuation as you tweak inputs.
  • Preloaded Data: Comes equipped with Vincerx Pharma’s actual financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making educated choices.

Who Should Use This Product?

  • Investors: Accurately assess Vincerx Pharma’s fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Vincerx Pharma (VINC).
  • Consultants: Quickly tailor the template for valuation reports focused on Vincerx Pharma (VINC) for clients.
  • Entrepreneurs: Acquire insights into financial modeling practices utilized by leading pharmaceutical companies.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies applicable to the biotech sector.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations specific to Vincerx Pharma, Inc. (VINC).
  • Real-World Data: Vincerx Pharma’s historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
  • Financial Statements: Full annual and quarterly breakdowns for deeper insights into Vincerx Pharma's performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage tailored to Vincerx Pharma, Inc. (VINC).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to Vincerx Pharma, Inc. (VINC).